Resources from the same session
Neoadjuvant Therapy for Rectal Cancer: Less or More Chemotherapy and/or Radiotherapy – When and How? Lessons From Recent Studies
Presenter: Michel Ducreux, France
Session: Session IX: Colon and Rectal Cancer: Early Disease
Resources:
Webcast
O-12: Phase II Study of Preoperative (Preop) Chemoradiotherapy (CTTRT) Plus Avelumab (AVE) In Patients (PTS) With Locally Advanced Rectal Cancer (LARC): The AVANA Study
Presenter: Lisa Salvatore, Italy
Session: Session IX: Colon and Rectal Cancer: Early Disease
Resources:
Webcast
SO-30: Efficacy and Safety of Neoadjuvant Short-Course Radiation Followed by mFOLFOX-6 plus Avelumab for Locally-Advanced Rectal Adenocarcinoma: Averectal Study
Presenter: Ali Shamseddine, Lebanon
Session: Session IX: Colon and Rectal Cancer: Early Disease
Resources:
Webcast
Discussant/Lecture: O-12, SO-30, Immunotherapy and Chemoradiotherapy for Rectal Cancer
Presenter: Eric Deutsch, France
Session: Session IX: Colon and Rectal Cancer: Early Disease
Resources:
Slides
Webcast
Neoadjuvant Therapy for Rectal Cancer: Less or More Chemotherapy and/or Radiotherapy – When and How? Lessons From Recent Studies: Perspective of A Clinical Oncologist
Presenter: Robert Glynne-Jones, United Kingdom
Session: Session IX: Colon and Rectal Cancer: Early Disease
Resources:
Slides
Webcast
Neoadjuvant Therapy for Rectal Cancer: Less or More Chemotherapy and/or Radiotherapy – When and How? Lessons From Recent Studies: Panel Discussion
Presenter: Michel Ducreux, France
Session: Session IX: Colon and Rectal Cancer: Early Disease
Resources:
Slides
Webcast